<i>Methods:</i> A comprehensive scoping review was conducted across electronic databases up to October 2025, including studies focusing on GJB2-associated HL, gene therapy approaches, and the timing of interventions. The gene discussed is GJB2; the disease is Hodgkins lymphoma.